NU Skin Enterprises Inc
NYSE:NUS
Intrinsic Value
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. [ Read More ]
The intrinsic value of one NUS stock under the Base Case scenario is 25.77 USD. Compared to the current market price of 12.7 USD, NU Skin Enterprises Inc is Undervalued by 51%.
Valuation Backtest
NU Skin Enterprises Inc
Run backtest to discover the historical profit from buying and selling NUS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
NU Skin Enterprises Inc
Current Assets | 701.9m |
Cash & Short-Term Investments | 267.8m |
Receivables | 72.9m |
Other Current Assets | 361.2m |
Non-Current Assets | 1.1B |
PP&E | 523.1m |
Intangibles | 336.1m |
Other Non-Current Assets | 245.4m |
Current Liabilities | 328.9m |
Accounts Payable | 43.5m |
Accrued Liabilities | 260.4m |
Other Current Liabilities | 25m |
Non-Current Liabilities | 655.6m |
Long-Term Debt | 478m |
Other Non-Current Liabilities | 177.6m |
Earnings Waterfall
NU Skin Enterprises Inc
Revenue
|
2B
USD
|
Cost of Revenue
|
-611.9m
USD
|
Gross Profit
|
1.4B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
68.1m
USD
|
Other Expenses
|
-59.5m
USD
|
Net Income
|
8.6m
USD
|
Free Cash Flow Analysis
NU Skin Enterprises Inc
What is Free Cash Flow?
NUS Profitability Score
Profitability Due Diligence
NU Skin Enterprises Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
NU Skin Enterprises Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
NUS Solvency Score
Solvency Due Diligence
NU Skin Enterprises Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
NU Skin Enterprises Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NUS Price Targets Summary
NU Skin Enterprises Inc
According to Wall Street analysts, the average 1-year price target for NUS is 15.81 USD with a low forecast of 14.14 USD and a high forecast of 17.85 USD.
Ownership
NUS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
NUS Price
NU Skin Enterprises Inc
Average Annual Return | 2.29% |
Standard Deviation of Annual Returns | 27.45% |
Max Drawdown | -80% |
Market Capitalization | 628.7m USD |
Shares Outstanding | 49 664 400 |
Percentage of Shares Shorted | 5.32% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.
Contact
IPO
Employees
Officers
The intrinsic value of one NUS stock under the Base Case scenario is 25.77 USD.
Compared to the current market price of 12.7 USD, NU Skin Enterprises Inc is Undervalued by 51%.